Funding Opportunity RFA-DK-18-013 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites new and renewal applications to participate in the Consortium on Modeling Autoimmune Interactions (CMAI). CMAI is a component of the Human Islet Research Network (HIRN) that is focused on developing robust systems to measure and model the biology of human type 1 diabetes. Projects will explore and validate research models designed to advance pre-clinical scientific discovery, mechanistic dissection of disease processes, and testing of potential interventions for T1D.

Notice NOT-AR-19-033 from the NIH Guide for Grants and Contracts

Notice NOT-HS-19-004 from the NIH Guide for Grants and Contracts

Notice NOT-DA-18-048 from the NIH Guide for Grants and Contracts

Notice NOT-DK-19-005 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-OD-19-014 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) intends to publish a Funding Opportunity Announcement (FOA) to establish 5 new awards for the Research Evaluation and Commercialization Hubs (REACH) program to address the problems that hinder the critical, early steps necessary to translate novel scientific advances and discoveries into commercially viable diagnostics, devices, therapeutics, and tools that improve patient care and advance public health. The five awardees will participate in a technology development consortium that incorporates best practices from current pilot programs and fulfills the objectives of the Phase 0 Proof of Concept Partnership pilot program, in accordance with Section 5127 of the 2011 SBIR/STTR Reauthorization Act (P.L. 112-81) and reauthorized through FY 2022 within H.R. 5515 Sec 854. The REACH program advances FY2020 Administration Research and Development Budget Priorities, including educating and training a workforce for the 21st century economy, transferring technology from the laboratory to the marketplace, and partnering with industry and academia to advance the RandD enterprise.

Funding Opportunity PAR-19-104 from the NIH Guide for Grants and Contracts. As part of the Gabriella Miller Kids First Pediatric Research Program (Kids First), the NIH invites applications to submit samples from pediatric cohorts for whole genome sequencing at a Kids First-supported sequencing center. Applicants are encouraged to propose sequencing of existing pediatric cancer cohorts to elucidate the genetic contribution to childhood cancers, or to expand the range of disorders included within the Kids First Data Resource to investigate the genetic etiology of structural birth defects. Whole genome, exome, and transcriptome sequencing may be available for tumor or affected tissue when justified. These data will become part of the Gabriella Miller Kids First Pediatric Data Resource (Kids First Data Resource) for the pediatric research community.

Negotiable: Paramount Recruitment: Senior Scientist Machine Learning - Bioinformatics Senior level, permanent, Immunology! A fantastic new opportunity has become available for a Bioinformatics Scientist specialising in Machine Learning to join a biopharma company in Baden-Wuerttember Baden-Württemberg, Germany

Negotiable: Paramount Recruitment: Clinical Bioinformatician Bioinformatics, Permanent, Rare Diseases and Cancer! Paramount are working in partnership with Genomics England who have successfully completed their 100,000 Genomes Project and are now working with the NHS to create the w London, England

Negotiable: Paramount Recruitment: Rare Disease Analyst - Permanent 100,000 Genomes Project - Bioinformatics - Central London Paramount are working in partnership with Genomics England to expand their team in order to deliver success with the 100,000 Genomes Project. London, England

Negotiable: Paramount Recruitment: Support Bioinformatician Genomics, Permanent, Research Services Team! Paramount are working in partnership with Genomics England to help expand their team - after successfully completing the 100,000 Genomes Project recently they are working together London, England

Negotiable: Paramount Recruitment: Senior Rare Disease Analyst Bioinformatics, Central London, Permanent! Paramount are working in partnership with Genomics England to expand their team in order to deliver success with the 100,000 Genomes Project. London, England

Funding Opportunity RFA-HD-19-023 from the NIH Guide for Grants and Contracts. The primary purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary approaches to the development of new and/or improved contraceptive methods for both men and women through the formation of a Contraceptive Research Center. This FOA also allows the inclusion of translational studies to facilitate the pre-clinical to clinical transition and increase the likelihood of clinical success, and also behavioral and social science research projects to study contraceptive use and non-use of marketed products or products in clinical development. The Center will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research.

Notice NOT-DA-18-049 from the NIH Guide for Grants and Contracts

Notice NOT-NS-19-025 from the NIH Guide for Grants and Contracts

Notice NOT-AR-19-031 from the NIH Guide for Grants and Contracts

Areas of expertise may include bioinformatics, computational biology, computer vision, systems biology, synthetic biology, structural biology, biophysics,...
From University of Wyoming - Thu, 13 Dec 2018 15:20:01 GMT - View all Laramie, WY jobs

Notice NOT-GM-19-008 from the NIH Guide for Grants and Contracts

Notice NOT-EB-18-035 from the NIH Guide for Grants and Contracts

Notice NOT-NR-18-024 from the NIH Guide for Grants and Contracts